Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Omnicom brews Olixir from FCB Health, rebrands storied agency after acquiring Interpublic
By healthadmin
Omnicom Health put its name on the recently acquired FCB Health New York, rebranding the…
The FDA’s Pharmacy Compounding Advisory Committee is scheduled to meet this summer to discuss whether…
In industry’s latest OTC strategy, Daiichi Sankyo plans to sell $1.5 billion in consumer health products to beverage giant Suntory
By healthadmin
As Daiichi Sankyo’s priorities become increasingly tied to its portfolio of innovative medicines, particularly in…
Gilead expands global Eztugo access agreement, but MSF says supply is ‘almost not enough’
By healthadmin
Despite new supply commitments from Gilead Sciences, Médecins Sans Frontières/Médecins Sans Frontières (MSF) is poking…
Novartis CEO Vasu Narasimhan joins Anthropic board as the relationship between biopharmaceuticals and AI deepens
By healthadmin
AI giant Anthropic has appointed Novartis CEO Vasu Narasimhan to its board of directors, as…
Astellas’ manufacturing chief sees reliable supply, translational research as the ‘north star’ of production
By healthadmin
For Astellas Pharma Chief Manufacturing Officer Dr. Rao Mantri, who has been in the role…
Actor, producer and artist Lucy Liu has joined Pfizer’s mission to end cancer, becoming the…
Drug development leaders face intensifying pressures from AI-accelerated discovery, expanding clinical pipelines, biopharma manufacturing shifts, and stringent FDA approvals in 2026.
Travele receives breakthrough rare disease approval, charting path towards Filspari’s $3 billion US opportunity
By healthadmin
With the path to a blockbuster product in sight, Travele Therapeutics is ready to hit…
Lilly has been directed to gather more safety information for obesity product launch Foundayo
By healthadmin
Even as Eli Lilly embarks on the launch of its next big obesity drug with…